Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

Much Clinical Trial Information Remains Concealed, Despite Promise To Disclose More Data

Main Category: Pharma Industry / Biotech Industry
Article Date: 01 Jun 2005 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The New York Times on Tuesday examined how the pharmaceutical industry remains "sharply divided" on how much information it reveals to the public about new and completed clinical studies. Journal editors and academic scientists in the last year have urged the industry to disclose more data after several drug companies failed to publish studies that showed their antidepressant medications were as effective as placebos (Berenson, ...New York Times, 5/31). Jeffrey Drazen, editor in chief of the New England Journal of Medicine, said last week that GlaxoSmithKline, Merck and Pfizer are not providing useful data on clinical trials they register on the site. In September 2004, the members of the International Committee of Medical Journal Editors announced that they will cease publishing studies that are not registered in an NIH database -- ClinicalTrials.gov -- at the time of their launches. The Pharmaceutical Research and Manufacturers of America and three other major pharmaceutical associations earlier this year recommended to their members that they submit clinical trial information to the public registry beginning in July (Kaiser Daily Health Policy Report, 5/24). According to the Times, "continued gaps in disclosure" have led to support among some members of Congress for new federal laws on the issue. Legislation proposed in February by Sens. Christopher Dodd (D-Conn.) and Chuck Grassley (R-Iowa) would convert ClinicalTrials.gov into a national registry for new studies and results and impose civil penalties of up to $10,000 per day for companies that fail to release trial data. However, Dodd said the bill's chances of passing in this Congress are uncertain (New York Times, 5/31).

The New York Times

"Reprinted with permission from kaisernetwork.org kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Forum Icon

Pharma Industry Forum

Discuss issues relating to pharma industry / biotech industry in our new forum.

Visit the pharma industry forum


These are the most read articles from this news category for the last 6 months:
Top Article Star
Criticism Of Popular Oral Contraceptive Yaz Could Harm Product's Appeal, New York Times Reports
29 Sep 2009
The popular oral contraceptives Yaz and Yasmin have been tainted recently by safety concerns raised by researchers, health advocates and lawyers for plaintiffs who have filed lawsuits against manufacturer Bayer Healthcare, the New York Times reports...


What You Need to Know about Drug Interactions
What You Need to Know about Drug Interactions

When it comes to drug interactions - what you don't know can hurt you.

more videos are available in our health videos section.